An article means nothing, probably because the people who write them are journalists with no clue of the hair loss industry.
Perfect example:
Bitmopost (allergen)
Collapse
X
-
I heard a lot about Bimatoprost 6 months ago but all that talk seems to have completely dried up. Unfortunate as it sounds promising.Leave a comment:
-
I'm pretty sure this was the report he was talking about:On the Bald Truth show a couple of weeks ago JFSI mentioned a news report on Allergen's Latisse being used for hairloss. He said it was the best news report on hairloss he had ever seen in his life and that there were pictures of guys with NW6's who had grown considerably more hair. It sounded extremely promising.
Spencer asked Joe to post a link to the report on the forum but it didn't sound like he was going to.
Does anyone have the link for this report?
Drugs For Eyelash Growth, Prostate Enlargement Repurposed To Stop Baldness
There's a video of the report in the link also.Leave a comment:
-
No. Because JFSI doesn't actually do anything apart from talk the talk or complain like the bald b00b that he is.
JFSI - put your money where your mouth is son!!Leave a comment:
-
On the Bald Truth show a couple of weeks ago JFSI mentioned a news report on Allergen's Latisse being used for hairloss. He said it was the best news report on hairloss he had ever seen in his life and that there were pictures of guys with NW6's who had grown considerably more hair. It sounded extremely promising.
Spencer asked Joe to post a link to the report on the forum but it didn't sound like he was going to.
Does anyone have the link for this report?Leave a comment:
-
If its a alternative with less shedding and no sides I'm going to buy it!!!!Leave a comment:
-
Any updates coming for this soon?
Isn't it going into phase III this year?
Still very interested in this, even if it's a simple alternative to minoxidil, the more options the better. You never know what could work well for you.Leave a comment:
-
For what's its worth.
The company: Allergan Inc.
Headquarters: Irvine
Ticker: AGN
Employees: 10,800
Leadership: David E.I. Pyott, chief executive since 1998
Revenue: $5.8 billion in 2012
Net income: $1.1 billion in 2012
Stock price: $108.60 at Friday's close
52-week range: $81.28 to $109.31
P/E ratio: 22.8 based on 2013 estimated earnings
Annual dividend: 5 cents, a current yield of about 0.2%
The business
This is the company that makes Botox. The wrinkle-erasing drug is Allergan's top-selling product — with sales expected to reach $2 billion in 2013.
But there's more to Allergan than wrinkle medicine. The self-described "multi-specialty healthcare company" also sells breast implants, a prescription drug that enhances eyelashes, a line of ophthalmic pharmaceuticals and, at least for now, the Lap-Band weight-loss device.
The company reported record sales of $5.8 billion in 2012 and expects robust sales again this year —$5.9 billion to $6.2 billion. Its stock hit an all-time high of $109.31 on Feb. 19]
Let's not forget Allergen. They got deep pockets and a foot in the game.Leave a comment:
-
[QUOTE=Pate;88057]I agree, bim is the treatment most likely to actually reach the market IMO. 2016 is realistic too. CB is the nearest competitor but prob more like 2017 for that. It would be so good if CB and bim could replace fin and minox, I think nearly every guy could at least maintain and most would have at least some regrowth. And instead of 7 pills and 14 applications a week you are using CB twice a week and bim once a day.
And your dick will still work. It's pretty shameful that it'll be nearly 2020 before we can hopefully consign the dinosaurs fin & minox to the pharmaceutical scrap heap. This crap is 80s technology.
Unfortunately those of us already at high NWs will of course need more, but at least the younger guys coming through will hopefully have a viable treatment to hang on to their hair.[/QUOTE/]
I'm already a NW9 so cluck it.Leave a comment:
-
I agree, bim is the treatment most likely to actually reach the market IMO. 2016 is realistic too. CB is the nearest competitor but prob more like 2017 for that. It would be so good if CB and bim could replace fin and minox, I think nearly every guy could at least maintain and most would have at least some regrowth. And instead of 7 pills and 14 applications a week you are using CB twice a week and bim once a day.
And your dick will still work. It's pretty shameful that it'll be nearly 2020 before we can hopefully consign the dinosaurs fin & minox to the pharmaceutical scrap heap. This crap is 80s technology.
Unfortunately those of us already at high NWs will of course need more, but at least the younger guys coming through will hopefully have a viable treatment to hang on to their hair.Leave a comment:
-
For the Phase 3 time I included the time it would take to forumlate the study, recruit subjects, do the study, and tabulate results.Confused on your math here. I was under the assumption a Phase III takes one year to complete not two. Also FDA approval takes a maximum of 9 months, not 1.5 years(doesnt take 6 months of commercials on top of that, maybe a few weeks.)
2016 at the latest for bim, you're looking at beyond a worse case scenario. Although I am curious about this IIb, what constitutes skipping IIb and going straight to III?
okay maybe 1 year for FDA approval + commercialization
Phase 2 results will determine if they go to Phase 3 or do Phase 2B trial to improve results.
So....late 2016.
I wish you were right, i have high hopes for Bim. I KNOW it will be much more effective than minoxidil just based on the science behind it and its mechanism of action. Obviously Allergan agrees or the wouldnt spend millions doing these trials.Leave a comment:
-
Confused on your math here. I was under the assumption a Phase III takes one year to complete not two. Also FDA approval takes a maximum of 9 months, not 1.5 years(doesnt take 6 months of commercials on top of that, maybe a few weeks.)False.
I have done lots of research on Allergan and Bimatoprost. It is the only treatment I really see happening within 5 years.
1. Data wont even be public until June 2013 for phase II results
2. If it is not significantly better than minoxidil they will do an entire phase IIB study and increase dosage (add 1.75 years)
3. If it is successful they will do a phase III (add 2 years beginning in June 2013)
4. FDA approval + commercializing product (1.5 years).
Therefore,
2017 if the P2 results are promising, which I am confident they will be if all they have to do is beat minoxidil's lousy effectiveness. Minoxidil = rat piss.
2016 at the latest for bim, you're looking at beyond a worse case scenario. Although I am curious about this IIb, what constitutes skipping IIb and going straight to III?Leave a comment:
-
False.
I have done lots of research on Allergan and Bimatoprost. It is the only treatment I really see happening within 5 years.
1. Data wont even be public until June 2013 for phase II results
2. If it is not significantly better than minoxidil they will do an entire phase IIB study and increase dosage (add 1.75 years)
3. If it is successful they will do a phase III (add 2 years beginning in June 2013)
4. FDA approval + commercializing product (1.5 years).
Therefore,
2017 if the P2 results are promising, which I am confident they will be if all they have to do is beat minoxidil's lousy effectiveness. Minoxidil = rat piss.Leave a comment:
-
2019? Let's not get too crazy. we're looking at 2015 for the early stuff(Bim), 2016-2017 for the crazier stuff(Histogen, aderans etc.)this is so damn annoying. Allergan will have the results analyzed by Jan/Feb, yet they will not share those results until a medical conference in JUNE?!?. I almost feel like big pharma loves to move at a snails pace. I give up on looking for new treatments.
It is a massive waste of time and mental energy.
FACT: No newer treatments will be available until atleast 2019.
2019 is 7 years, I dont think any clinical trials with positive results will last that long. If Bim continues with positive results, it's about 2, maybe 3 years away.Leave a comment:
-
this is so damn annoying. Allergan will have the results analyzed by Jan/Feb, yet they will not share those results until a medical conference in JUNE?!?. I almost feel like big pharma loves to move at a snails pace. I give up on looking for new treatments.
It is a massive waste of time and mental energy.
FACT: No newer treatments will be available until atleast 2019.Leave a comment:
Leave a comment: